Omeros seeks FDA OK for cataract surgery drug; shares up
This article was originally published in Scrip
Executive Summary
Omeros is seeking the FDA's approval for OMS302 for use in patients undergoing intraocular lens replacement (ILR) surgeries, such as cataract surgery and refractive lens exchange.